Clinical Trial Update: FearLess in NeuroOncology [NA]

View source ↗

Summary

Clinical trial update for FearLess in NeuroOncology indicates the study is currently recruiting for patients with glioblastoma and other primary brain tumors, i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Brain Tumor
• Glioblastoma
• Oligodendroglioma

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Primary Malignant Brain Tumor, Glioblastoma (GBM) | NA | Status: RECRUITING